Expression of cell cycle associated proteins influences radiocurability of T2N0 squamous cell carcinoma of the larynx

Oral Oncology

Volumn 44, Issue 10, 2008, Pages 975-981

  Rafferty, M ^a   Helliwell, T R ^a   Husband, D J ^b   Fenton, J ^a   Jones, T M ^a   Jones, A S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

Cure; Cyclin D1; Epidermal growth factor receptor; Ki 67; Larynx; Radiation; Retinoblastoma protein; Squamous cell carcinoma

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; LABELING INDEX; LARYNX CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; TUMOR BIOPSY; TUMOR LOCALIZATION;

AGED; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN D1; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOBLASTOMA PROTEIN; SURVIVAL ANALYSIS;

EID: 51649103327     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.12.007     Document Type: Article

References (41)

1. Sobin L.H., and Wittekind C. TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
2. Shah J.P., Karnell L.H., Hoffman H.T., Ariyan S., Brown G.S., Fee W.E., et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 123 (1997) 475-483
3. Mendenhall W.M., Parsons J.T., Stringer S.P., Cassisi N.J., and Million R.R. T1-T2 vocal cord carcinoma: a basis for comparing the results of radiotherapy and surgery. Head Neck 10 (1988) 373-377
4. Viani L., Stell P.M., and Dalby J.E. Recurrence after radiotherapy for glottic carcinoma. Cancer 67 (1991) 577-584
5. Wang C.C. Radiation therapy for head and neck neoplasms (1997), Wiley-Liss, Inc., New York
6. McLaughlin M.P., Parsons J.T., Fein D.A., Stringer S.P., Cassisi N.J., Mendenhall W.M., et al. Salvage surgery after radiotherapy for T1-T2 squamous cell carcinoma of the glottic larynx. Head Neck 18 (1996) 229-235
7. Fein D.A., Mendenhall W.M., Parsons J.T., and Million R.R. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Rad Oncol Biol Phys 25 (1993) 605-611
8. Smith B.D., Haffty B.G., and Sasaki C.T. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance. Ann Otol Rhinol Laryngol 110 (2001) 221-228
9. Capaccio P., Pruneri G., Carboni N., Pagliari A.V., Buffa R., Neri A., et al. Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas. J Laryngol Otol 11 (1997) 622-626
10. Bellacosa A., Almadori G., Cavallo S., Cadoni G., Galli J., Ferrandina G., et al. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2 (1996) 175-180
11. Jares P., Fernandez P.L., Campo E., Nadal A., Bosch F., Aiza G., et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54 (1994) 4813-4817
12. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J., and Livingston D.M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73 (1993) 487-497
13. Muller H., Lukas J., Schneider S., Warthoe P., Bartek J., Eilers M., et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Nat Acad Sci 91 (1994) 2945-2949
14. Jiang W., Zhang Y.J., Kahn S.M., Hollstein M.C., Santella R.M., Lu S.H., et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Nat Acad Sci 90 (1993) 9026-9030
15. Ishikawa T., Furihata M., Ohtsuki Y., Murakami H., Inoue A., and Ogoshi S. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 77 (1998) 92-97
16. Stampfer M.R., Pan C.H., Hosoda J., Bartholomew J., Mendelsohn J., and Yaswen P. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. Exp Cell Res 208 (1993) 175-188
17. O'Charoenrat P., Rhys-Evans P.H., Modjtahedi H., and Eccles S.A. The role of c-erb receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol 38 (2002) 627-640
18. Eriksen J.G., Steinche T., Askaa J., Alsner J., and Overgaard J. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Rad Oncol Biol Phys 58 (2004) 561-566
19. Baumann M., and Krause M. Targetting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72 (2004) 257-266
20. Karamouzis M.V., Grandis J.R., and Argiris A. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. JAMA 298 (2007) 70-82
21. Cruz J.J., Ocana A., Del Barco E., and Pandiella A. Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer. Ann Oncol 18 (2007) 421-430
22. Couture C., Raybaud-Diogene H., Tetu B., Bairati I., Murray D., Allard J., et al. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 94 (2002) 713-722
23. Motamed M., Banerjee A.R., Bradley P.J., and Powe D. MIBI-1 and p53 expression in radiotherapy-resistant T1a N0 M0 glottic squamous cell carcinoma. Clin Otolaryngol 26 (2001) 227-230
24. Roland N.J., Caslin A.M., Bowie G.L., and Jones A.S. Has the cellular proliferation marker Ki-67 any clinical relevance in squamous cell carcinoma of the head and neck?. Clin Otolaryngol 19 (1994) 13-18
25. Sittel C., Eckel H.E., Damm M., von Pritzbuer E., and Kvasnicka H.M. Ki-67 (MIBI), p53, and Lewis-X (LeuMI) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 110 (2000) 1012-1017
26. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet ii (1986) 307-310
27. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35 (1977) 1-39
28. Cox D.R. Regression models and life tables. J Roy Statist Soc B34 (1972) 187-220
29. Maurizi M., Almadori G., Ferrandina G., Distefano M., Romanini M.E., Cadoni G., et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74 (1996) 1253-1257
30. Yokoyama J., Shiga K., Sasanoi I., Suzuki M., and Takasaka T. Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancer. Anticancer Res 16 (1996) 641-644
31. Ridge J.A. Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence. Semin Oncol 20 (1993) 419-429
32. Snow G.B., Patel P., Lemmas C.R., and Toward R. Management of cervical lymph nodes in patients with head and neck cancer. Otorhinolaryngol 249 (1992) 187-194
33. Glanz H., Kimmich T., Eichhorn T., and Kleinsasser O. Results of treatment of 584 laryngeal cancers at the Ear-Nose-Throat Clinic of Marburg University. Head Neck Oncol 1989 (1989) 1-10
34. Yoo S.S., Carter D., Turner B.C., Sasaki C.T., Son Y.H., Wilson L.D., et al. Prognostic significance of cyclin D1 protein levels in early stage larynx cancer treated with primary radiation. Int J Cancer 90 (2000) 22-28
35. De Bono J.S., and Rowinsky E.K. The erbB receptor family: a therapeutic target for cancer. Trends Mol Med 8 (2002) S19-S26
36. Sheridan M.T., O'Dwyer T., Seymore C.B., and Mothersill C.E. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiat Oncol Invest 5 (1997) 180-186
37. Eriksen J.G., Steiniche T., and Overgaard J. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma. Acta Oncol 44 (2005) 50-58
38. Wen Q.H., Mia T., Yoshiazaki T., Nagayama I., Furukawa M., and Nishijima H. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope 106 (1996) 884-888
39. Grandis J.R., Chokaborky A., Melhem M.F., Zeng Q., and Tweardy D.J. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous cancers but not normal mucosal epithelial cells. Oncogene 15 (1997) 409-416
40. Jones A.S. The molecular cell biology of head and neck cancer with clinical applications. Section 1: Fundamental biology and the basis of cancer. Clin Otolaryngol 29 (2004) 475-491
41. Kropveld A., Slootweg P.J., Blankenstein M.A., and Terhaard C.H. J HG. Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope 108 (1998) 1548-1552